INTERNATIONAL FLAVORS & FRAGRANCES INC

IFF 10-K · FY 2025
API behind this page

IFF FY 2025 request

Playground key active
Request URL /api/financials?ticker=IFF&year=2025&quarter=4&full_year_mode=true
waiting 0 ms 
Pick an endpoint and run the request.
curl

Income Statement

JSON CSV Excel
Income Statement
Metric FY 2025 FY 2024 YoY
Revenue 10,890 11,484 -5.2%
Show Business Segments breakouts
Food Ingredients · Operating Segments 3,278 3,365 -2.6%
Health & Biosciences · Operating Segments 2,283 2,203 +3.6%
Pharma Solutions · Operating Segments 369 1,049 -64.8%
Scent · Operating Segments 2,479 2,439 +1.6%
Taste · Operating Segments 2,481 2,428 +2.2%
Show Geography breakouts
Asia 2,546 2,731 -6.8%
EMEA 3,727 3,840 -2.9%
Latin America 1,422 1,473 -3.5%
North America 3,195 3,440 -7.1%
Show Consolidation Items breakouts
Operating Segments 10,890 11,484 -5.2%
Show Geographic Distribution breakouts
Non Us 7,815 8,265 -5.4%
US 3,075 3,219 -4.5%
Cost of Revenue 6,952 7,360 -5.5%
Show Business Segments breakouts
Food Ingredients · Operating Segments 2,531 2,626 -3.6%
Health & Biosciences · Operating Segments 1,246 1,183 +5.3%
Pharma Solutions · Operating Segments 248 719 -65.5%
Scent · Operating Segments 1,424 1,361 +4.6%
Taste · Operating Segments 1,500 1,470 +2.0%
Gross Profit 3,938 4,124 -4.5%
Research & Development 694 671 +3.4%
Show Business Segments breakouts
Food Ingredients · Operating Segments 54 71 -23.9%
Health & Biosciences · Operating Segments 219 190 +15.3%
Pharma Solutions · Operating Segments 8 25 -68.0%
Scent · Operating Segments 241 225 +7.1%
Taste · Operating Segments 172 160 +7.5%
Selling, General & Administrative 1,834 1,995 -8.1%
Show Business Segments breakouts
Food Ingredients · Operating Segments 400 391 +2.3%
Health & Biosciences · Operating Segments 348 368 -5.4%
Pharma Solutions · Operating Segments 42 115 -63.5%
Scent · Operating Segments 366 376 -2.7%
Taste · Operating Segments 396 403 -1.7%
Operating Income -382 766 -149.9%
Interest Expense 229 305 -24.9%
Interest Income 19 15 +26.7%
Other Non-Operating Income (Expense) 65 182 -64.3%
Income Before Taxes -412 308 -233.8%
Income Tax Expense (Benefit) -53 41 -229.3%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment Including Portion Attributable To Noncontrolling Interest · Reclassification Out Of Accumulated Other Comprehensive Income -1 -47 +97.9%
Show Income Tax Expense, Component [Axis] breakouts
Global Intangible Low-Taxed Income (GILTI) 215 — —
Tax Credit, Foreign -178 — —
Net Income -359 267 -234.5%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment Including Portion Attributable To Noncontrolling Interest · Reclassification Out Of Accumulated Other Comprehensive Income 46 -93 +149.5%
Comprehensive Income 736 -368 +300.0%
EPS (Basic) -1.41 1.04 -235.6%
EPS (Diluted) -1.41 1.04 -235.6%
Wtd Avg Shares (Basic) 256 256 0.0%
Wtd Avg Shares (Diluted) 256 256 0.0%
Net Income Loss Available To Common Stockholders Basic -361 263 -237.3%
Net Income Loss Attributable To Noncontrolling Interest 2 4 -50.0%
Foreign Currency Transaction Gain Loss Before Tax -92 -91 -1.1%

Balance Sheet

Balance Sheet
Metric FY 2025 FY 2024 YoY
Current Assets
Cash & Cash Equivalents 590 469 +25.8%
Inventory 2,245 2,133 +5.3%
Total Current Assets 5,594 7,968 -29.8%
Non-Current Assets
Property, Plant & Equipment 4,029 3,739 +7.8%
Show Geography breakouts
Non Us 2,409 2,129 +13.2%
US 1,620 1,610 +0.6%
Operating Lease Right-of-Use Assets 579 589 -1.7%
Show Disposal Group Classification breakouts
Disposal Group Heldforsale Not Discontinued Operations · SCL Disposal Group 7 — —
Goodwill 8,269 9,075 -8.9%
Show Business Segments breakouts
Health & Biosciences 4,465 4,295 +4.0%
Scent 1,508 1,465 +2.9%
Taste 2,296 — —
Intangible Assets 6,043 6,445 -6.2%
Other Non-Current Assets 1,025 907 +13.0%
Total Assets 25,539 28,723 -11.1%
Current Liabilities
Accounts Payable 1,287 1,283 +0.3%
Commercial Paper 314 — —
Current Portion of Long-Term Debt -1,254 -1,413 +11.3%
Total Current Liabilities 3,933 4,352 -9.6%
Debt Current 1,254 1,413 -11.3%
Non-Current Liabilities
Long-Term Debt 4,740 7,564 -37.3%
Long-Term Debt 5,637 — —
Operating Lease Liabilities 533 550 -3.1%
Deferred Tax Liabilities 1,379 1,594 -13.5%
Other Non-Current Liabilities 582 627 -7.2%
Stockholders' Equity
Common Stock 35 35 0.0%
Retained Earnings -3,417 -2,647 -29.1%
Accumulated Other Comprehensive Income -1,430 -2,527 +43.4%
Total Stockholders' Equity 14,154 13,834 +2.3%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment -153 -99 -54.5%
Accumulated Gain Loss Net Cash Flow Hedge Parent -4 -2 -100.0%
Accumulated Other Comprehensive Income -1,430 -2,527 +43.4%
Accumulated Translation Adjustment -1,273 -2,426 +47.5%
Total Liabilities & Equity 25,539 28,723 -11.1%

Cash Flow Statement

Cash Flow Statement
Metric FY 2025 FY 2024 YoY
Operating Activities
Depreciation & Amortization 962 1,015 -5.2%
Stock-Based Compensation 88 77 +14.3%
Deferred Income Taxes -270 -323 +16.4%
Change in Accounts Receivable -68 -217 +68.7%
Change in Inventory -41 -34 -20.6%
Change in Accounts Payable -57 40 -242.5%
Net Cash from Operations 850 1,070 -20.6%
Investing Activities
Capital Expenditures -594 -463 -28.3%
Net Cash from Investing 2,269 326 +596.0%
Financing Activities
Share Repurchases -38 — —
Tax Withholding for Share Compensation -24 -16 -50.0%
Debt Repayments (FY) — — —
Show Debt Instrument breakouts
Senior Notes, Euro Notes, 2024 · Loans Payable 500 — —
Net Cash from Financing -3,091 -1,606 -92.5%
Supplemental
Income Taxes Paid 329 — —
Interest Paid 229 308 -25.6%
Unpaid Capital Expenditures 176 158 +11.4%
Other Cash Flow
Net Change in Cash 119 -264 +145.1%

Values in millions USD. Source: SEC EDGAR 10-K filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key